Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 49
  • Journal CiteScore: 11.20
  • Journal Impact Factor: 8.24
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Fang Bai

Fang Bai
Associate Professor Microbiological and biochemical drugs College of Pharmacy Nankai University

Biography

Fang Bai earned her B.S. in Biotechnology Pharmaceuticals (2003) from Jilin University and his Ph.D. in Microbiology (2008) from College of Life Sciences, Nankai University, China. From 2008 to 2013, Dr. Bai worked in anti-diabetic drugs development and mechanism study at College of pharmacy, Nankai University, China. In 2013, Dr. Bai went to USA to pursue her two-years postdoctoral training at College of medicine, University of Florida. Her focus is to study the bacterial Type III secretion system based protein delivery technology and its application in stem cells reprogramming or differentiation. Dr. Bai now is an associate professor of College of Pharmacy and the State Key Laboratory of Medicinal Chemical Biology, Nankai University, China. She is the PI for several city and national level research projects, including: the National Natural Science Foundation of China, the Tianjin Municipal Science and Technology Commission of China.

Research Interest

Type 2 diabetes drug discovery: Intestinal Glycoside Hydrolases (?-Amylase, Maltase-Glucoamylase and Sucrase-Isomaltase) and theirs inhibitors. Bioactive microbial metabolites produced by Streptomyces sp. Type III secretion system (T3SS) of Pseudomonas aeruginosa: Regulation of the T3SS, Applications. Protein Delivery System in Cellular Biology (Stem Cells). Discovery of Innovative Antibacterial Agents and mechanism study.